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Abstract
Background. There is no widely accepted objective evaluation 
for lumbar spine disorders. New outcome measures should 
be patient-oriented and should measure symptoms and self-
reported functional status in multiple dimensions. The aim of 
this study was to identify items to be included in the disease-
specifi c quality of life (QOL) questionnaire for the assess-
ments of patients with lumbar spine disorders.
Methods. The draft of the QOL questionnaire that consisted 
of a total of 60 items, including 24 items derived from the 
Japanese version of the Roland Morris Disability Question-
naire (RDQ) and 36 items derived from the Japanese version 
of Short Form 36 (SF-36), were administered to patients and 
controls. After obtaining written informed consent, the follow-
ing data were collected from the patient group (n = 328) and 
the control group (n = 213): (1) background characteristics, 
including age, diagnosis, Japanese Orthopaedic Association 
(JOA) score, and fi nger to fl oor distance; (2) responses to the 
questionnaire; (3) the identifi cation rate by discrimination 
analysis to select the candidates for adoption and by adopting 
explanatory variables. The items to be excluded were deter-
mined by examining the explanatory variables, which were 
selected after the discrimination analysis, by setting the can-
didate to-be-excluded items as an objective variable.
Results. Based on the distribution of the responses, two items, 
RDQ-15 and RDQ-19, were excluded. From the results of 
the correlation coeffi cient calculation for each question in the 
patient group, 33 items were excluded and 27 candidate items 
were adopted. Based on the adoption explanatory variable 
used in the discrimination analysis, 25 of the 27 candidate 
items for adoption were accepted.
Conclusions. This study identifi ed the 25 specifi c questionnaire 
items that should be included in the questionnaire to evaluate 
QOL of patients with various lumbar spine disorders.
Introduction
The assessments of lumbar spine disorders have been 
based on biological, physiological, and anatomical 
outcomes, such as measurements of the range of spinal 
motion, laboratory tests, and imaging studies.1 However, 
these indicators have little meaning for the patient and 
the society. On the other hand, alleviation of symptoms, 
such as pain intensity, and an improved quality of life 
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(QOL) have more signifi cance for the patients and the 
society. It has been reported that patient self-rated 
measures of symptom intensity and QOL are as repro-
ducible as many physiological measurements and are 
acceptable with respect to objectivity and stability.2 
Thus, patient-based outcomes involving patient self-
assessment of symptom intensity and QOL should be 
used in clinical research.
Conventionally, surgery is evaluated based on a 
simple four-grade scale: excellent, good, fair, and poor. 
This approach has limitations due to its subjectivity and 
the lack of clear defi nitions for each grade. Therefore, 
the evaluation of treatment results depends on individ-
ual researchers and is not fully comparable. Further-
more, the four-grade scale is not suffi cient to measure 
pain intensity, activities of daily living, or the ability to 
work. For example, a patient might not be able to return 
to work despite a decrease in pain, or there may be no 
alleviation of pain intensity despite an improvement in 
activities of daily living. Given such circumstances, an 
improvement in one dimension does not necessarily 
mean an improvement in other dimensions; thus, the 
evaluation of medical treatments must be multidimen-
sional and include patient-based outcomes. Given these 
perspectives, the Assessment Standards Committee 
prepared this report dealing with the new standards for 
evaluating the results of treatments for lumbar spine 
disorders.
Materials and methods
Selection of lumbar spine disorders evaluation items
The aim of this study was to establish a multidimen-
sional method for evaluating treatment results for 
lumbar spine disorders that was centered on patient-
based outcomes and that could be used internationally. 
Pain intensity can be measured using a visual analogue 
scale (VAS) and the NASS questionnaire.3,4 The 
Roland-Morris disability questionnaire (RDQ) and the 
Oswestry disability questionnaire are low back pain-
specifi c QOL questionnaires.5,6 With respect to the 
RDQ, the Japanese version of the RDQ has been devel-
oped that conforms to the psychometric standards in the 
areas of reliability, validity, and responsiveness.7 Both 
alleviation of patients’ symptoms and its impact on their 
activities of daily living can be measured using the 
RDQ. Widely used international measures for general 
well-being include the SF36, SF12, and the Euro QOL; 
Japanese versions of the SF36 and the Euro QOL have 
been developed.8–11 Thus, it would be desirable to use 
the VAS for measuring the intensity of low back pain, 
the RDQ for measuring low back pain-specifi c QOL, 
and the SF-36 for assessing general well-being. However, 
the evaluation of all of these items in daily practice is 
impractical owing to the large number of items. The 
approximate time to complete the RDQ is 5 min, and 
it takes 10 min to complete the SF36.1 To reduce the 
number of items necessary to evaluate the effi cacy of 
treatments for lumbar spine disorders, the usefulness 
of various evaluation criteria to differentiate patients 
with lumbar spine disorders from normal subjects was 
studied.
Examination of the evaluation rating score (true value) 
in the lumbar spine disorders group
Eight institutions (including affi liated institutions) were 
asked to recruit at least 40 subjects during the period 
from February to May 2002. The questionnaire con-
sisted of a total of 60 items: 24 items derived from the 
Japanese version of the RDQ and 36 items derived from 
the Japanese version of the SF-36. Lumbar disc hernia-
tion and lumbar canal stenosis were the two main 
targets. Subjects who had other orthopedic disorders 
and those with impaired ability to understand the ques-
tions, such as patients with dementia, were excluded. 
Normal subjects were defi ned as adults with no ortho-
pedic disorders. Adults living independently and not 
requiring nursing care but who were undergoing alter-
native treatments (e.g., acupuncture, moxibustion, 
massage, and chiropractic treatments) were included 
in the control group. Health care professionals were 
excluded.
Prior to conducting the investigations, subjects in the 
patient group and the control group gave their written 
informed consent.
Background characteristics of the patient group
The distribution of subjects’ background characteristics, 
such as age, diagnosis, Japanese Orthopaedic Associa-
tion (JOA) score, and fi nger to fl oor distance, was ana-
lyzed to verify that the group represents the general 
population of patients with spine disorders.
Examination of removable candidate QOL items
A QOL item could be removed if it satisfi ed any of the 
following criteria: (1) items to which most subjects gave 
the same answer; (2) items the answers for which were 
highly correlated with the answers to other questions; 
(3) items that could be explained by several questions; 
(4) items whose score distributions did not show any 
statistically signifi cant differences between the patient 
and control groups.
To test for the above conditions, the distribution of 
responses for the RDQ and SF36 were compared 
between the two groups. The correlation coeffi cient for 
each question in the patient group was analyzed using 
the Spearman correlation coeffi cient.
M. Fukui et al.: JOA Back Pain Evaluation Questionnaire 445
Examination of the identifi cation rate by discrimination 
analysis of candidate items
After using the above-described criteria to identify the 
candidate items to be included in the fi nal question-
naire, discrimination analysis was done to eliminate 
further the number of items. By setting one of the can-
didate items for adoption as the objective variable, the 
rest of the items were examined as explanatory vari-
ables; the discrimination rate was then analyzed, and 
items with a minimum discrimination rate ≥70% were 
considered to be items that could be excluded. The fi nal 
items that were excluded were determined by examin-
ing the explanatory variables, which were selected after 
discrimination analysis, setting the candidate to-be-
excluded items as the objective variable.
Results
Background characteristics of the patient group
Table 1 shows the age, sex, and diagnosis of 328 subjects 
in the patient group and 213 subjects in the control 
group. There was signifi cant difference in sex and age 
distribution between the two groups (P = 0.03, Fisher’s 
exact test). In the patient group, the straight leg raising 
(SLR) test was positive in approximately 40%, sensory 
disturbance was present in 60%, muscle weakness was 
seen in 40%, and bladder dysfunction was impaired in 
approximately 10% of the subjects (Table 2). The dis-
tribution of the fi nger to fl oor distance revealed that the 
Table 1. Demogrphics of pateints and controls
Patients Controls
Male Female Total Male Female Total
187 159 346 96 120 216
Age group (years)
 10–19 1 2 3
 20–29 19 16 35 15 33 48
 30–39 23 13 36 18 22 40
 40–49 18 19 37 20 16 36
 50–59 30 29 59 15 21 36
 60–69 39 40 79 12 15 27
 70–79 47 32 79 12 12 24
 80–89 9 8 17  4  1 5
 ≥90 1 1
Diagnosis
 Lumbar disc herniation (LDH) 160
 Lumbar spinal canal stenosis (LCS) 183
 LDH + LCS 3
Other orthopedic disorders
 Present 18 3
 Absent 328 213
Table 2. Clinical fi ndings
Parameter Patients Control
328 213
SLR
 Normal 201 211
 30°–70° 110 1
 <30° 17 1
Sensory
 Normal 124 210
 Mild disturbance 150 2
 Obvious disturbance 54 1
Motor
 Normal 191 212
 Mild muscle weakness 107 0
 Obvious muscle weakness 30 1
Bladder function
 Normal 293 207
 Mild dysuria 33 6
 Severe dysuria 2 0
Finger-to-fl oor distance
  – −15 1 6
 −14 – −5 3 10
 −4 – 4 95 108
 5 – 14 68 54
 15 – 24 54 30
 25 – 34 51 5
 35 – 44 17 0
 45 – 54 24 0
 55 – 64 8 0
 65 – 74 1 0
 75 – 84 2 0
 Measurement not possible 4 0
SLR, straight-leg raising
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mobility of the lumbar spine in the patient group was 
signifi cantly restricted compared to that of the control 
group. Although we cannot make any conclusions, given 
the above results we considered that the patient group 
represented the general population of the patients with 
lumbar spine disorders.
RDQ
The nonresponse rate for the RDQ was less than 5% 
for all questions; no questions were diffi cult to answer. 
As expected, more than 95% of the normal subjects 
answered “no” to all questions. In the patient group, 
Table 3. Results of the RDQ (Roland-Morris Disability Questionnaire)
Question item
Patients (n = 328) Controls
Yes No No response Yes No No response
RDQ-1 174 148 6 1 212
 53.0% 45.1% 1.8% 0.5% 99.5%
RDQ-2 232 92 4 20 193
70.7% 28.0% 1.2% 9.4% 90.6%
RDQ-3 253 69 6 7 204 2
77.1% 21.0% 1.8% 3.3% 95.8% 0.9%
RDQ-4 110 210 8 2 211
33.5% 64.0% 2.4% 0.9% 99.1%
RDQ-5 183 135 10 4 209
55.8% 41.2% 3.0% 1.9% 98.1%
RDQ-6 215 109 4 3 208 2
65.5% 33.2% 1.2% 1.4% 97.7% 0.9%
RDQ-7 119 204 5 3 210
36.3% 62.2% 1.5% 1.4% 98.6%
RDQ-8 185 139 4 4 209
56.4% 42.4% 1.2% 1.9% 98.1%
RDQ-9 152 170 6 2 211
46.3% 51.8% 1.8% 0.9% 99.1%
RDQ-10 193 129 6 4 209
58.8% 39.3% 1.8% 1.9% 98.1%
RDQ-11 166 156 6 6 207
50.6% 47.6% 1.8% 2.8% 97.2%
RDQ-12 86 237 5 1 211 1
26.2% 72.3% 1.5% 0.5% 99.1% 0.5%
RDQ-13 128 195 5 11 202
39.0% 59.5% 1.5%  5.2% 94.8%
RDQ-14 162 159 7 2 211
49.4% 48.5% 2.1% 0.9% 99.1%
RDQ-15 53 270 5 212 1
16.2% 82.3% 1.5% 99.5% 0.5%
RDQ-16 166 157 5 3 209 1
50.6% 47.9% 1.5% 1.4% 98.1% 0.5%
RDQ-17 222 100 6 6 206 1
67.7% 30.5% 1.8% 2.8% 96.7% 0.5%
RDQ-18 114 210 4 2 210 1
34.8% 64.0% 1.2% 0.9% 98.6% 0.5%
RDQ-19 28 296 4 213
8.5% 90.2% 1.2% 100.0%
RDQ-20 109 211 8 1 212
33.2% 64.3% 2.4% 0.5% 99.5%
RDQ-21 263 58 7 7 206
80.2% 17.7% 2.1% 3.3% 96.7%
RDQ-22 105 219 4 4 209
32.0% 66.8% 1.2% 1.9% 98.1%
RDQ-23 257 65 6 10 203
78.4% 19.8% 1.8% 4.7% 95.3%
RDQ-24 82 242 4 213
25.0% 73.8% 1.2% 100.0%
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Table 4. Exclusion and adoption of items (fi rst level)
Excluded items Reason Items adopted
RDQ-3 RDQ-17, 23 Correlation RDQ-1
RDQ-7 RDQ-12 Correlation RDQ-2
RDQ-9 RDQ-16 Correlation RDQ-4
RDQ-10 RDQ-1, 17 Correlation RDQ-5
RDQ-15 Answers concentrated on NO RDQ-6
RDQ-19 Answers concentrated on NO RDQ-8
RDQ-21 RDQ-17,  23 Correlation RDQ-11
RDQ-24 RDQ-4 Correlation RDQ-12
QOL-2 QOL-1 Correlation RDQ-13
QOL-3a QOL-3g Correlation RDQ-14
QOL-3b QOL-3g Correlation RDQ-16
QOL-3c QOL-3e Correlation RDQ-17
QOL-3d QOL-3e, 3g Correlation RDQ-18
QOL-3h QOL-3e, 3g Correlation RDQ-20
QOL-3i QOL-3e, 3g Correlation RDQ-22
QOL-3j QOL-3e Correlation RDQ-23
QOL-4a QOL-8 Correlation QOL-1
QOL-4c QOL-8 Correlation QOL-3e
QOL-4d QOL-8 Correlation QOL-3f
QOL-5a QOL-8 Correlation QOL-3g
QOL-5b QOL-8, 9f Correlation QOL-4b
QOL-5c QOL-8, 9f Correlation QOL-8
QOL-6 QOL-8 Correlation QOL-9f
QOL-7 QOL-8 Correlation QOL-9g
QOL-9a QOL-9h Correlation QOL-9h
QOL-9b QOL-9f Correlation QOL-11b
QOL-9c QOL-9f Correlation QOL-11c
QOL-9d QOL-9f, 9h Correlation
QOL-9e QOL-9h Correlation
QOL-9i QOL-9g Correlation
QOL-10 QOL-8 Correlation
QOL-11a QOL-11b Correlation
QOL-11d QOL-1, 11b Correlation
more than 80% of respondents chose the same answers 
for items 15, 19, and 21; and approximately 80% chose 
the same answer for items 3 and 23. In particular, for 
items 15 and 19, more than 80% of the patient group 
chose the same answer (no) as the normal healthy 
subjects (Table 3). Therefore, based on these results, 
RDQ-15 and RDQ-19 were listed as candidates to be 
excluded.
SF-36
The nonresponse rate for the SF-36 was less than 5% 
for all questions, and none of the questions was diffi cult 
to answer. There was a statistically signifi cant difference 
in the distribution of responses between the patient 
group and the control group (P < 0.05, by χ2). Further-
more, there were no questions for which the answers 
were predominantly concentrated on one choice in the 
patient group.
Correlation coeffi cient for each question in 
the patient group
For the 24 RDQ items, there were mutual correlations 
between two groups of item s: RDQ-1, 3, 10, 17, 21, and 
23 (six items); and RDQ-4, 7, 9, 12, 16, and 24 (six 
items). For the SF-36 items, there were mutual correla-
tions among four groups: QOL-1,2,11a,11b, and 11d (5 
items); QOL-3a–3j (10 items); QOL-4a–4d, 5a–5c, 6, 7, 
8, and 10 (11 items); QOL-9a–9i (9 items). Thus, 33 
items were excluded, and 27 remained as candidates 
for adoption. The reasons for exclusion are shown in 
Table 4.
Discrimination analysis
The discrimination rate of the answer for each item, 
based on the discrimination analysis, was determined 
for the 27 candidates for adoption. To arrive at the 
discrimination rate, one item was set as the objective 
variable, and the other items were set as explanatory 
variables; the item with a high minimum value for the 
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Table 5. Results of discrimination analysis
Question item
Minimal ratio of
discrimination for 
each choice
Ratio of
discrimination
through all choices κ
RDQ-1 75.2%a 77.3%a 0.54
RDQ-2 60.5% 81.5%a 0.53
RDQ-4 66.7% 81.0%a 0.57
RDQ-5 74.8%a 80.1%a 0.59
RDQ-6 62.1% 80.5%a 0.55
RDQ-8 69.2% 76.7%a 0.52
RDQ-11 69.0% 72.7%a 0.45
RDQ-12 69.6% 87.0%a 0.65
RDQ-13 55.0% 68.8% 0.34
RDQ-14 70.6%a 74.5%a 0.49
RDQ-16 76.6%a 78.3%a 0.57
RDQ-17 64.2% 83.4%a 0.59
RDQ-18 60.0% 77.2%a 0.48
RDQ-20 61.0% 77.0%a 0.47
RDQ-22 44.4% 72.6%a 0.33
RDQ-23 57.1% 84.3%a 0.50
QOL-1 30.0% 56.2% 0.31
QOL-3e 52.8% 68.8% 0.45
QOL-3f 46.3% 61.5% 0.38
QOL-3g 50.0% 69.7% 0.50
QOL-4b 48.1% 58.2% 0.46
QOL-8 46.0% 55.9% 0.41
QOL-9f 36.7% 56.6% 0.41
QOL-9g 28.6% 47.1% 0.28
QOL-9h 14.3% 48.5% 0.28
QOL-11b 21.1% 48.3% 0.27
QOL-11c 5.6% 58.7% 0.23
a Discrimination rate >70%
discrimination rate was excluded from adoption. The 
minimum value for the discrimination rate was > 70% 
in four items (RDQ-1, 5, 14, and 16) (Table 5). The 
discrimination rate calculated the ratio that the answers 
of patients group accorded with the estimated answers 
by classifi cation rule. To compute the κ value, we made 
a contingency table using the answers of patients group 
and by the estimated answers.
Adoption of the explanatory variables in 
discrimination analysis
To verify whether it would be appropriate to exclude 
RDQ-1, 5, 14, and 16, the explanatory variable chosen 
for each objective variable in discrimination analysis 
was determined (Table 6). Consequently, it was found 
that if RDQ-1 and 5 were excluded RDQ-14 and 16 
could not be excluded because RDQ-1 and 5 would be 
necessary. Given these results, 25 of the 27 candidate 
items for adoption were adopted; RDQ-1 and 5 were 
excluded.
Discussion
Several issues must be considered when creating a new 
evaluation method for medical treatments. First, the 
evaluation should be structured so the effect of medical 
intervention is accurately refl ected. If medical treat-
ment results are mainly determined by genetic or envi-
ronmental factors, the quality of the treatment cannot 
be evaluated. Second, the evaluation of medical treat-
ment results must contain a framework that accurately 
and reliably captures changes in the patient’s health 
condition. Finally, to evaluate the medical treatment 
results accurately, the treatment evaluation period 
should be the same as the time period during which 
information is obtained about the patients’ complica-
tions and social background that can affect the medical 
treatment outcomes.
Evaluation of medical treatment outcomes used to be 
a subject of concern for health care professionals only. 
Recently, however, the evaluation of medical treatment 
outcomes is becoming more of a concern to patients and 
governments who pay the medical costs. Evaluating 
medical treatment results is key to assessing cost effec-
tiveness and to validating treatments themselves. Thus, 
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criteria used for the evaluations should be objective and 
structured in such a way that the patients’ perspective 
is respected. In this way, the results can be understood 
not only by health care professionals but also by patients 
and third parties. Evaluation of medical treatment 
based on the creation of standards can be used to docu-
ment and improve the performance of the medical 
system and health care technology.
This study has several limitations. There was a signifi -
cant difference in sex and age between the patients 
group and the normal group. Hence, there is a possibil-
ity that this difference affects the results of our study. 
For many research purposes, it may be optimal to 
include both disease-specifi c (RDQ) and generic func-
tional status measures (SF-36). However, an instrument 
that includes both disease-specifi c and general func-
tional status measures has not been established. 
Although it may not be ideal to combine items from two 
different instruments, our fi nal goal was to fi nd the 
disease-specifi c daily functions, physical function, role 
function, pain, vitality, mental health, and health per-
ception. However, only the Japanese version of the 
RDQ as the disease-specifi c and the Japanese version 
of the SF-36 as the generic functional status measure 
were available. Therefore, we combined items from the 
two instruments to fi nd the disease-specifi c functional 
status that included many dimensions.
We were able to identify 25 specifi c questions that 
would elucidate the QOL of patients with various 
lumbar spine disorders. The next step is to assess the 
validity and responsiveness of the questionnaire that 
includes the selected 25 questions by measuring the 
Table 6. Explanatory variable chosen for every objective variable on discrimination analysis
Objective variable
RDQ-1 RDQ-5 RDQ-14 RDQ-16
Minimum value of discrimination rate for every choice 75.2% 74.8% 70.6% 76.6%
All choices by discrimination rate 77.3% 80.1% 74.5% 78.3%
κ 0.54 0.59 0.49 0.57
Variable Explanation
RDQ-1 I stay at home most of the time because of my back. –  
RDQ-2 I change position frequently to try to get my back comfortable.  
RDQ-4 Because of my back, I am not doing any of the jobs that I usually 
do around the house.
  
RDQ-5 Because of my back, I use a handrail to get upstairs. – 
RDQ-6 Because of my back, I lie down to rest more often.  
RDQ-8 Because of my back, I try to get other people to do things for me.  
RDQ-11 Because of my back, I try not to bend or kneel down.   
RDQ-12 I found it diffi cult to get out of a chair because of my back.   
RDQ-13 My back is painful almost all the time.  
RDQ-14 I fi nd it diffi cult to turn over in bed because of my back.  – 
RDQ-16 I have trouble putting on my socks (or stockings) because of the 
pain in my back.
  –
RDQ-17 I only walk short distances because of my back.   
RDQ-18 I sleep less well because of my back.  
RDQ-20 I sit down for most of the day because of my back.   
RDQ-22 Because of my back pain, I am more irritable and bad tempered 
with people than usual.
 
RDQ-23 Because of my back, I go upstairs more slowly than usual.   
QOL-1 In general, would you say your health is:
QOL-3e Does your health now limit you in climbing one fl ight of stairs? 
QOL-3f Does your health now limit you in bending, kneeling, or 
stooping?
 
QOL-3g Does your health now limit you in walking more than a mile?  
QOL-4b Any problems as a result of your physical health: accomplished 
less than you would like?
QOL-8 How much did pain interfere with your normal work? 
QOL-9f Have you felt downhearted and blue?
QOL-9g Did you feel worn out?
QOL-9h Have you been a happy person?  
QOL-11b I am as healthy as anybody I know.   
QOL-11c I expect my health to get worse. 
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outcome of patients with lumbar spinal disorders. Also, 
we have to complete cross-cultural adaptation of the 
BPEQ so it can be used internationally.
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